Rchr
J-GLOBAL ID：200901000039588380
Update date: Mar. 01, 2024
KOBAYASHI Kunihiko
コバヤシ クニヒコ | KOBAYASHI Kunihiko
Affiliation and department：
Job title：
Professor
Homepage URL (1)：
http://homepage3.nifty.com/care-notebook/
Research theme for competitive and other funds (4)：
- 2006 - 2009 EGFR遺伝子変異を有する未治療進行非小細胞肺癌に対するゲフィチニブとプラチナ併用化学療法との無作為化比較試験
- 2005 - 2007 抗癌剤投薬の適応のない、EGFR遺伝子変異陽性非小細胞肺癌に対する初回Gefitinib救済治療
- 2003 - 2006 イリノテカン不応の既治療小細胞肺癌に対するパクリタキセル + ニムスチン(ACNU)併用第II相試験
- 2004 - 2005 EGFR遺伝子変異陽性非小細胞肺癌に対するGefitinib治療第2相試験
Papers (126)：
-
Fujita K, Arai R, Shoji S, Saito R, Nomura M, Hotta T, Asahina H, Kawakami M, Nakachi I, Hasegawa Y, et al. Detection of multiple druggable mutations of lung cancer from cytology specimens by MINtS: An advanced medicine A trial. Cancer Sci. 2023 May 3. 2023
-
Saito R, Sugawara S, Ko R, Azuma K, Morita R, Maemondo M, Oizumi S, Takahashi K, Kagamu H, Tsubata Y, et al. Phase 2 study of osimertinib in combination with platinum and pemetrexed in patients with previously untreated EGFR-mutated advanced non-squamous non-small cell lung cance. Eur J Cancer. 2023. 185. 83-93
-
Tsubata Y, Kawakado K, Hamai K, Furuya N, Yokoyama T, Saito R, Nakamura A, Masuda T, Hamaguchi M, Kuyama S, et al. Identification of risk factors for venous thromboembolism and validation of the Khorana score in patients with advanced lung cancer: based on the multicenter, prospective Rising-VTE/NEJ037 study data. Int J Clin Oncol. 2023. 28. 1. 69-78
-
Miyanaga A, Asahina H, Watanabe S, Shukuya T, Tsubata Y, Hosomi Y, Sugawara S, Maemondo M, Okano T, Morita S, et al. A Phase I/II Study of Necitumumab Plus Pembrolizumab, Nab-Paclitaxel, and Carboplatin for Previously Untreated Advanced Squamous Non-Small Cell Lung Cancer Study: (NEJ048A/NEXUS). Clin Lung Cancer. 2023 Jun;24(4):371-375. 2023. 24. 4. 371-375
-
Kaira K, Yamaguchi O, Kawasaki T, Hashimoto K, Miura Y, Shiono A, Mouri A, Imai H, Kobayashi K, Yasuda M, et al. Prognostic significance of tumor infiltrating lymphocytes on first-line pembrolizumab efficacy in advanced non-small cell lung cancer. Discov Oncol. 2023. 14. 1
ｍore...
MISC (1)：
-
Oizumi S, Takamura K, Harada T, Tachihara M, Morikawa N, Honda R, Watanabe S, Asao T, Kunisaki M, Fukuhara T, et al. Phase II study of carboplatin-paclitaxel alone or with bevacizumab in advanced sarcomatoid carcinoma of the lung: HOT1201/NEJ024. Int J Clin Oncol. 2022 Apr;27(4):676-683. 2022. 27. 4. 676-683
Books (2)：
-
「肺癌治療とQOL-臨床試験に焦点を当てて、Annual Review 2006 呼吸器」
中外医学者 2006
-
肺癌治療とQOL-臨床試験に焦点を当てて、Annual Review 2006 呼吸器
中外医学者 2006
Lectures and oral presentations (2)：
-
肺癌個化医療への道のり-NEJ 001 と 002 試験
(第56回日本肺癌学会学術集会 2015)
-
ワークショップ7 Intergroup Study - NEJ の立場から
(日本臨床腫瘍学会総会 2013)
Education (1)：
- 1977 - 1983 Nippon Medical School Faculty of Medicine
Professional career (1)：
Committee career (1)：
Awards (2)：
- 2012/12 - International Research Promotion Council (IRPC) World Scientists Forum International Award - Eminent Scientist of the Year 2012.
- 2011/04 - 文部科学大臣 科学技術賞
Return to Previous Page
